Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy
- 1 October 2015
- journal article
- case report
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 160 (4), 799-805.e1
- https://doi.org/10.1016/j.ajo.2015.07.012
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pericentral Retinopathy and Racial Differences in Hydroxychloroquine ToxicityOphthalmology, 2015
- Combined MTOR and autophagy inhibitionAutophagy, 2014
- Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanomaAutophagy, 2014
- A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiformeAutophagy, 2014
- Combined autophagy and HDAC inhibitionAutophagy, 2014
- Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year reviewSupportive Care in Cancer, 2012
- Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine RetinopathyOphthalmology, 2011
- Detection of Early Hydroxychloroquine Retinal Toxicity Enhanced by Ring Ratio Analysis of Multifocal ElectroretinographyAmerican Journal of Ophthalmology, 2007
- Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritisArthritis & Rheumatism, 2002
- Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: A randomized, double-blind six-week trial with eighteen-week extensionArthritis & Rheumatism, 1999